ESC 365 is the cardiology knowledge hub where you’ll find resources, whenever you want them from congresses, webinars, courses, publications and podcast.

Limited data are available on the impact of anxiety and/or depression on clinical outcomes in patients with atrial fibrillation (AF).

BMC Medicine - Stressful life events (SLEs) in adulthood are potential risk factors for cardiovascular disease (CVD), yet evidence remains inconsistent. This study examined the association between...

Atrial fibrillation (AF) remains the most common arrhythmia worldwide and a major contributor to mortality and morbidity from stroke and heart failure (HF). Despite growing recognition that AF behaves...

In this large European–Asian cohort of patients with atrial fibrillation, liver disease was linked to lower oral anticoagulant use—particularly in Europe—and to higher risks of mortality and cardiova...

Abstract. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and inflammation has been suggested as a predisposing factor for AF. Sy

This prespecified secondary analysis of a randomized clinical trial investigates the effectiveness of a village doctor–led, telemedicine-supported integrated care model among patients aged 75 years an...

AbstractBackground and Aims. Heart failure (HF) presents a significant and growing public health challenge. The aim of this study was to develop and valida

Journal of Human Hypertension - C-reactive protein and residual cardiovascular risk in hypertension: a prospective cohort study

Antiphospholipid antibodies (aPL) are associated with an elevated risk of thromboembolic events in patients with antiphospholipid syndrome and, increasingly, in those without previous thrombosis. In t...

In the era of non-vitamin K antagonist oral anticoagulants (NOACs), it remains unclear whether rate control versus rhythm control as an initial treatment strategy affects the prognosis of patients wit...

AbstractAims. To evaluate differences in clinical characteristics and outcomes based on physical activity levels in patients with atrial fibrillation (AF),

The latest data release from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2023 has enabled us to conduct an updated analysis of the trends and burdens of common metabolic disea...

AbstractAims. The association between socioeconomic deprivation and atrial fibrillation (AF) remains debated, with limited evidence on its interaction with

AbstractAims. To compare long-term outcomes of patients with Takotsubo syndrome (TTS) and heart failure (HF).Methods and Results. This retrospective observ

Aortic dissection (AD) is a catastrophic vascular disorder with an incidence between 0.61 and 7.2/100 000 people.1 In type A acute AD, surgery aims to prev

AbstractBackground and Aims. A recent European trial found that in frail elderly patients with atrial fibrillation (AF), switching from well-managed warfar

Background Limited data are available on the risk of pancreatic adverse events among people with obesity or type 2 diabetes mellitus (T2DM) initiating glucagon-like peptide-1 receptor agonist (GLP-1 R...

Cardiovascular Diabetology - Erythrocytosis has emerged as a hematologic response to sodium–glucose cotransporter 2 (SGLT2) inhibitor therapy, yet its occurrence and potential impact on...

Cardiovascular-Kidney-Metabolic (CKM) syndrome integrates metabolic risk factors, chronic kidney disease (CKD), and cardiovascular dysfunction, and is…

AbstractIntroduction. The global burden of heart failure (HF) is rising, with a shift towards more cases of heart failure with preserved ejection fraction

Structured AbstractBackground and Aims. Cardiovascular-kidney-metabolic (CKM) syndrome reflects the interplay of cardiovascular disease (CVD), chronic kidn

AbstractAims. Stroke is the second leading cause of death and the third leading cause of disability worldwide. We performed a systematic review and meta-an

Purpose of Review Recent advances have underscored the importance of interactions between the gut microbiota, vascular system and brain in stroke pathogenesis. This review introduces the conceptual fr...

Abstract. A significant proportion of patients with atrial fibrillation (AF) who need thromboembolic protection are not treated with or discontinue oral an

AbstractAims. Atrial fibrillation (AF) is a progressive condition characterized by atrial remodeling and dysfunction. This systematic review explores bioma

AbstractBackground and Aim. Susceptibility to hypertension-mediated organ damage (HMOD) is influenced by genetics, age, gender, and additional cardiovascul

AbstractBackground and Aims. Atrial fibrillation (AF) disease burden is increasing. Pharmacotherapy of cardio-renal-metabolic diseases may prevent incident

Introduction Atrioventricular node (AVN) ablation after pacemaker implantation is a rate control option for patients with symptomatic atrial fibrillation (AF) when rhythm control with anti-arrhythmi...

AbstractAims. The ABCStroke pathway is a structured, person-centred approach to post-stroke care encompassing antithrombotic therapy, functional and psycho

Background Heart failure attributable to atrial fibrillation/flutter (HF-AF/AFL) represents a growing global public health challenge. However, comprehensive analyses of its long-term trends, the indep...